Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways
Journal of Experimental & Clinical Cancer Research volume 40, Article number: 277 (2021)
Retraction Note: J Exp Clin Cancer Res 35, 152 (2016)
The Editor-in-Chief has retracted this article at the request of Wen-Ting Liao. The author stated that the data presented in Fig. 2F (HE and Ki67) were published in the authors’ previous study , and the data in Figs. 1C (α-tubulin, FOXO3, p-AKT) and 2A (α-tubulin) were published in . In addition, the same α-tubulin western blot bands are presented in Figs. 2A and 3A. Thus, the corresponding author stated that the authors have no confidence in the reliability of the data and conclusions reported in this article. Run-Wei Yang, Ying-Yue Zeng, Wen-Ting Wei, Yan-Mei Cui, Hui-Ying Sun, Li Liang, and Wen-Ting Liao agree to this retraction. Yue-Long Cai, Xin-Xin Nian, Yun-Teng Hu, Yu-Ping Quan, Sheng-Lu Jiang, Meng Wang, Ya-Li Zhao, Jun-Feng Qiu, Ming-Xuan Li, Jia-Huan Zhang, Mei-Rong He, and Yan-Qing Ding have not responded to any correspondence about this retraction.
Cui Y-M, Jiang D, Zhang S-H, Wu P, Ye YP, Chen CM, et al. FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways. Cancer Lett. 2014;353(1):87–94. https://doi.org/10.1016/j.canlet.2014.07.008.
Cui YM, Jiao HL, Ye YP, Chen CM, Wang JX, Tang N, et al. FOXC2 promotes colorectal cancer metastasis by directly targeting MET. Oncogene. 2015;34(33):4379–90. https://doi.org/10.1038/onc.2014.368.
About this article
Cite this article
Yang, RW., Zeng, YY., Wei, WT. et al. Retraction Note: TLE3 represses colorectal cancer proliferation by inhibiting MAPK and AKT signaling pathways. J Exp Clin Cancer Res 40, 277 (2021). https://doi.org/10.1186/s13046-021-02079-2